skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: Base de dados/Biblioteca: RCN full-text journals@Ovid remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Apple juice and the chemical-contact softening of gallstones
Apple juice and the chemical-contact softening of gallstones
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apple juice and the chemical-contact softening of gallstones

Dekkers, R

The Lancet (British edition), 1999-12, Vol.354 (9196), p.2171-2171 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
PHP297 - CHANGES IN ULTRA-ORPHAN DRUG ASSESSMENTS IN POLAND
PHP297 - CHANGES IN ULTRA-ORPHAN DRUG ASSESSMENTS IN POLAND
Material Type:
Artigo 		Adicionar ao Meu Espaço

PHP297 - CHANGES IN ULTRA-ORPHAN DRUG ASSESSMENTS IN POLAND

Vaithyanathan, G. ; Dekkers, R. ; van Engen, A.

Value in health, 2018-10, Vol.21, p.S201-S201 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000
The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000
Material Type:
Artigo 		Adicionar ao Meu Espaço

The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000

Couper, Gregory S ; Dekkers, Rene J ; Adams, David H

The Annals of thoracic surgery, 1999-08, Vol.68 (2), p.646-649 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
4
PSY157 - Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors
PSY157 - Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

PSY157 - Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

Kreeftmeijer, J ; Dekkers, R ; van Engen, A

Value in health, 2016-11, Vol.19 (7), p.A603-A603 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Time Trends In Sequence Of Drug Launch Across Eu5
Time Trends In Sequence Of Drug Launch Across Eu5
Material Type:
Artigo 		Adicionar ao Meu Espaço

Time Trends In Sequence Of Drug Launch Across Eu5

Gubbels, L ; Dekkers, R ; Nijhuis, T

Value in health, 2016-11, Vol.19 (7), p.A451-A451 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
PHP68 - Time Trends In Sequence Of Drug Launch Across Eu5
PHP68 - Time Trends In Sequence Of Drug Launch Across Eu5
Material Type:
Artigo 		Adicionar ao Meu Espaço

PHP68 - Time Trends In Sequence Of Drug Launch Across Eu5

Gubbels, L ; Dekkers, R ; Nijhuis, T

Value in health, 2016-11, Vol.19 (7), p.A451-A451 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors
Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

Kreeftmeijer, J ; Dekkers, R ; van Engen, A

Value in health, 2016-11, Vol.19 (7), p.A603-A603 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure
Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure

Dekkers, Renè J ; FitzGerald, Daniel J ; Couper, Gregory S

Perfusion, 2001-01, Vol.16 (1), p.13-18 [Periódico revisado por pares]

Thousand Oaks, CA: SAGE Publications

Texto completo disponível

Citações Citado por
9
PCN331 - Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
PCN331 - Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCN331 - Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

Duran, A ; Morlock, R ; Lie, X ; Dekkers, R ; Gani, R ; van Engen, A ; Holmstrom, S

Value in health, 2017-10, Vol.20 (9), p.A471-A471 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

Duran, A ; Morlock, R ; Lie, X ; Dekkers, R ; Gani, R ; van Engen, A ; Holmstrom, S

Value in health, 2017-10, Vol.20 (9), p.A471 [Periódico revisado por pares]

Lawrenceville: Elsevier Science Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (18)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (18)
  2. Reports  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1995  (3)
  2. 1995Até2000  (6)
  3. 2001Até2014  (2)
  4. 2015Até2017  (7)
  5. Após 2017  (2)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.